Literature DB >> 19349155

Casting light on harm reduction: introducing two instruments for analysing contradictions between harm reduction and 'non-harm reduction'.

Michael Jourdan1.   

Abstract

BACKGROUND: Harm reduction is commonly regarded as complementary to other drug problem responses--as the fourth tier. Yet even core examples of harm reduction such as the provision of injection equipment and methadone treatment have over and over encountered considerable opposition, and harm reduction in its more comprehensive forms continuously stirs up controversy. In spite of this the notion of complementarity is commonly upheld leaving opposition to harm reduction inexplicable and non-researchable.
METHODS: Teaching experience in multiple settings in which opposing views have surfaced and a review of relevant literature on contradictions involved in drug policy debates have been utilized to analyse and summarize policy contradictions involved implicitly or explicitly in disagreements on harm reduction.
RESULTS: Analysing contradictions is a difficult endeavour, but many opposing views appear if you approach the task systematically. For this purpose two instruments have been constructed: 'The Harm Reduction Inventory' (25 items) and 'The Drug Policy Propensity Index' (11 items). These tentative instruments are presented in full and their potentials are discussed.
CONCLUSION: Harm reduction may in fact represent goals, methods, priorities and understandings which are to a considerable extent at odds with the opposite of harm reduction--here termed 'non-harm reduction'. This insight may be overlooked if assuming complementarity. To describe and analyse harm reduction by way of juxtaposing opposites seems a feasible and illuminative approach. The instruments provided could perhaps facilitate better understanding of conflicts of vision and contribute towards illuminating policy barriers.

Entities:  

Mesh:

Year:  2009        PMID: 19349155     DOI: 10.1016/j.drugpo.2009.02.011

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  4 in total

1.  Heroin: from drug to ambivalent medicine : on the introduction of medically prescribed heroin and the emergence of a new space for treatment.

Authors:  Birgitte Schepelern Johansen; Katrine Schepelern Johansen
Journal:  Cult Med Psychiatry       Date:  2015-03

2.  Preferences for evidence-based practice dissemination in addiction agencies serving women: a discrete-choice conjoint experiment.

Authors:  Charles E Cunningham; Joanna Henderson; Alison Niccols; Maureen Dobbins; Wendy Sword; Yvonne Chen; Stephanie Mielko; Karen Milligan; Ellen Lipman; Lehana Thabane; Louis Schmidt
Journal:  Addiction       Date:  2012-04-17       Impact factor: 6.526

3.  Harm reduction drug policy in Israel: what has been accomplished and what still needs to be done?

Authors:  Hagit Bonny-Noach
Journal:  Isr J Health Policy Res       Date:  2019-10-16

4.  How a concerned family member, friend or member of the public can help someone with gambling problems: a Delphi consensus study.

Authors:  Kathy S Bond; Anthony F Jorm; Helen E Miller; Simone N Rodda; Nicola J Reavley; Claire M Kelly; Betty A Kitchener
Journal:  BMC Psychol       Date:  2016-02-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.